Tekla Capital Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Tekla Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $2.06 Million - $3.06 Million	-20,623 Reduced 22.71%	70,176 $9.67 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $8.98 Million - $12.6 Million	90,799 New	90,799 $12.6 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $2.23 Million - $3.37 Million	-34,277 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $315,831 - $808,142	-10,887 Reduced 24.11%	34,277 $2.51 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $441,232 - $918,874	16,039 Added 55.07%	45,164 $1.54 Million
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $1.09 Million - $1.44 Million	29,125 New	29,125 $1.22 Million
Q2 2018 Aug 13, 2018	SELL	$23.62 - $42.29 $3.84 Million - $6.87 Million	-162,477 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $3.65 Million - $5.62 Million	162,477 New	162,477 $4.19 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.